Design of Novel Polymer Micro-Porous Coatings. This project utilises unique polymer structures that self-organise into highly-ordered polymer films. These polymer films have arrays of pores with pore diameters on the micron scale. These films are suitable for high-technology membranes applications, in for instance, biosensors.
Novel Hydrogels for Bioseparations in Clinical Applications. The project aims to design and synthesise new highly swollen hydrophilic membranes for use in biological separation processes and purifications such as the removal of viruses from blood. Typical membrane problems like membrane fouling or low flux should be minimized by a narrow pore size distribution. The regular nano-patterning should be obtained by molecular impriniting technique. Novel thermoresponsive polymers, which will be polyme ....Novel Hydrogels for Bioseparations in Clinical Applications. The project aims to design and synthesise new highly swollen hydrophilic membranes for use in biological separation processes and purifications such as the removal of viruses from blood. Typical membrane problems like membrane fouling or low flux should be minimized by a narrow pore size distribution. The regular nano-patterning should be obtained by molecular impriniting technique. Novel thermoresponsive polymers, which will be polymerized via controlled free radical polymerization techniques, will be used as biocompatible membrane material.Read moreRead less
Design of Polymeric Devices for Biotechnological Applications. The research project focuses on the development of functional polymer particles for diagnostic applications. Advanced polymer chemistry will be used to synthesize devices for reliable and fast diagnostic systems. The outcome of this work will help promoting and maintaining good health in Australia by developing novel technologies and advanced materials based on polymer science.
Polymer Stabilized and Bio-functionalised Metal Nanoparticles As Potential Vectors For Drug Therapies. The project aims to make novel nanoparticles (extremely small, nano means one billionth of a metre) that carry medicines to very specific sites of the body and then release them. This would result in much improved outcomes for conventional chemotherapy but may also allow new gene therapies where diseases can be silenced at their source.
Multivalent drug delivery carrier for the targeted delivery of platinum anticancer agents to hepatocytes. Hepatocellular carcinoma (HCC) is often treated with chemotherapy using cytotoxic drugs. This systemic treatment results in the distribution of the drug throughout the body. Employing a polymer particle as a drug carrier for these drugs ensures a temporal control of the release and therefore supply of the drug within the body. By attaching carbohydrate moieties onto the surface of the polyme ....Multivalent drug delivery carrier for the targeted delivery of platinum anticancer agents to hepatocytes. Hepatocellular carcinoma (HCC) is often treated with chemotherapy using cytotoxic drugs. This systemic treatment results in the distribution of the drug throughout the body. Employing a polymer particle as a drug carrier for these drugs ensures a temporal control of the release and therefore supply of the drug within the body. By attaching carbohydrate moieties onto the surface of the polymer particle the drug carrier can specifically be recognized by cell receptors, thus allowing a targeted delivery of the drug to the desired area in the body. A range of carbohydrate-based drug carriers will be synthesized and tested towards their interaction with hepatocytes to allow optimisation of this drug carrier system.
Read moreRead less
Core-shell nanoparticle from polymers with pendant cyclodextrins. A better drug delivery system will be developed for the treatment of cancer with albendazole. These nanoparticles enhance the circulation time in the body, but also facilitate the delivery of the drug to the site of the tumour, which will increase the efficacy of the treatment. The nanoparticles are obtained by processing polymers with pendant cyclodextrin groups, which are a type of complex sugars. Aim of this work is the explora ....Core-shell nanoparticle from polymers with pendant cyclodextrins. A better drug delivery system will be developed for the treatment of cancer with albendazole. These nanoparticles enhance the circulation time in the body, but also facilitate the delivery of the drug to the site of the tumour, which will increase the efficacy of the treatment. The nanoparticles are obtained by processing polymers with pendant cyclodextrin groups, which are a type of complex sugars. Aim of this work is the exploration of synthetic routes to generate nanoparticles. Tailoring the underpinning polymer structure of these nanoparticles will allow the optimisation of the release of albendazole from the drug carrier, thus improving cancer treatment.Read moreRead less
Degradable hollow microspheres for liver cancer treatment. The expected outcome of this multidisciplinary approach is a controlled drug delivery system for the treatment of liver cancer. We aim to increase the understanding of drug release using polymeric microspheres and the influence of the polymer properties on the release kinetics resulting in the tailored drug release for liver cancer treatment. An indepth knowledge in drug delivery can lead to optimised release kinetics leding to an increa ....Degradable hollow microspheres for liver cancer treatment. The expected outcome of this multidisciplinary approach is a controlled drug delivery system for the treatment of liver cancer. We aim to increase the understanding of drug release using polymeric microspheres and the influence of the polymer properties on the release kinetics resulting in the tailored drug release for liver cancer treatment. An indepth knowledge in drug delivery can lead to optimised release kinetics leding to an increased patient convenience and life prolonging treatments.Read moreRead less
Platinum drugs containing core-shell nanoparticles. Many drugs such as cancer drugs contain metal ions. While the therapeutic benefits of metal containing drugs are highly promising, their administration is often accompanied by substantial side effects. Encapsulation of these drugs into nano-sized core-shell particles will prolong the circulation of the drug and therefore reduce the amount of repeated administrations. In addition, the shape and nature of the particle will enable the targeted del ....Platinum drugs containing core-shell nanoparticles. Many drugs such as cancer drugs contain metal ions. While the therapeutic benefits of metal containing drugs are highly promising, their administration is often accompanied by substantial side effects. Encapsulation of these drugs into nano-sized core-shell particles will prolong the circulation of the drug and therefore reduce the amount of repeated administrations. In addition, the shape and nature of the particle will enable the targeted delivery of these drug loaded nanocarriers to the tumor while healthy tissue remains unaffected. Read moreRead less
Triggering the release of polymer bound platinum drugs. Platinum drugs are found to be highly efficient as anti-cancer drugs. Their side-effects however, limit their application. Nanoparticles are developed that bind the platinum drug tightly as long as the drug circulates in the blood stream, but releases the drug as soon as it reaches the tumour. To treat prostate cancer, the nanoparticle will be attached to a targeting moiety - a monoclonal antibody - that facilitates the effective delivery t ....Triggering the release of polymer bound platinum drugs. Platinum drugs are found to be highly efficient as anti-cancer drugs. Their side-effects however, limit their application. Nanoparticles are developed that bind the platinum drug tightly as long as the drug circulates in the blood stream, but releases the drug as soon as it reaches the tumour. To treat prostate cancer, the nanoparticle will be attached to a targeting moiety - a monoclonal antibody - that facilitates the effective delivery to the prostate cancer cells, but leaves healthy cells unaffected. This proposal aims to develop suitable synthetic pathway to enhance the treatment of cancer by using appropriate delivery vehicles. Read moreRead less